News
Economic Times
Apr 2, 2024
Scrut Automation raises $10 million in funding round from existing investors
Governance, risk and compliance (GRC) platform Scrut Automation said it will use the funds to strengthen its platform capabilities, incorporate generative AI use cases to reduce the manual effort for risk and compliance teams, and expand to North American and European markets.
Economic Times
Apr 2, 2024
Eyestem to begin human trials for its pioneering Dry AMD treatment
Dry AMD, a leading cause of vision loss in the ageing population of people over 50, has long been a challenge due to the limited availability of effective treatments and the high costs associated with emerging therapeutic options.
Startup Story
Mar 14, 2024
Sugar.fit secures $5 million extension in Series A funding round
Healthtech startup Sugar.fit has secured an additional $5 million in Series A funding led by B Capital, bringing the total funding raised in the round to $16 million. Existing investors MassMutual Ventures, Tanglin Venture Partners, Endiya Partners, and Cure.Fit also participated in the round. The startup will use the fresh capital to enhance Sugar.fit’s technology stack and product range, increase brand presence, and accelerate research and development in diabetes management.
The Hindu BusinessLine
Feb 25, 2024
Eyestem’s promising pipeline of products catches the eye of traditional pharma companies
Two pharmaceutical companies and a vaccine-maker invested in Eyestem (2022), putting the spotlight on the cell therapy company’s product pipeline. The six-year old company’s potential therapy for dry age-related macular degeneration, a global unmet medical need, awaits regulatory approvals in India for trial in humans, even as the company prepares to take the investigational new drug to Australia, says Eyestem co-founder and Chief Executive Jogin Desai.
2022 All rights reserved
